These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20943682)

  • 1. Targeting vaccination against novel infections: risk, age and spatial structure for pandemic influenza in Great Britain.
    Keeling MJ; White PJ
    J R Soc Interface; 2011 May; 8(58):661-70. PubMed ID: 20943682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal H1N1 vaccination strategies based on self-interest versus group interest.
    Shim E; Meyers LA; Galvani AP
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S4. PubMed ID: 21356133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling mitigation strategies for pandemic (H1N1) 2009.
    Gojovic MZ; Sander B; Fisman D; Krahn MD; Bauch CT
    CMAJ; 2009 Nov; 181(10):673-80. PubMed ID: 19825923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.
    Bolton KJ; McCaw JM; Brown L; Jackson D; Kedzierska K; McVernon J
    PLoS One; 2015; 10(3):e0120138. PubMed ID: 25811654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal strategies of social distancing and vaccination against seasonal influenza.
    Shim E
    Math Biosci Eng; 2013; 10(5-6):1615-34. PubMed ID: 24245639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.
    Chowell G; Viboud C; Wang X; Bertozzi SM; Miller MA
    PLoS One; 2009 Dec; 4(12):e8164. PubMed ID: 19997603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling optimal age-specific vaccination strategies against pandemic influenza.
    Lee S; Golinski M; Chowell G
    Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neighborhood determinants of 2009 pandemic A/H1N1 influenza vaccination in Montreal, Quebec, Canada.
    Brien S; Kwong JC; Charland KM; Verma AD; Brownstein JS; Buckeridge DL
    Am J Epidemiol; 2012 Nov; 176(10):897-908. PubMed ID: 23077284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.
    de Whalley P; Walker W; Snape MD; Oeser C; Casey M; Moulsdale P; Harrill C; Andrews N; Hoschler K; Thompson B; Jones C; Chalk J; Kerridge S; Tomlinson R; Heath PT; Finn A; Faust S; Miller E; Pollard AJ
    Health Technol Assess; 2011 Dec; 15(45):v-vi, xi-xiii, 1-128. PubMed ID: 22257497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.
    Kelso JK; Halder N; Milne GJ
    BMC Infect Dis; 2013 Feb; 13():81. PubMed ID: 23398722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritization of influenza pandemic vaccination to minimize years of life lost.
    Miller MA; Viboud C; Olson DR; Grais RF; Rabaa MA; Simonsen L
    J Infect Dis; 2008 Aug; 198(3):305-11. PubMed ID: 18558871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.
    Baguelin M; Hoek AJ; Jit M; Flasche S; White PJ; Edmunds WJ
    Vaccine; 2010 Mar; 28(12):2370-84. PubMed ID: 20096762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of delayed vaccination for pandemic influenza.
    Shim E
    Math Biosci Eng; 2011 Jan; 8(1):95-112. PubMed ID: 21361402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic (H1N1) 2009 influenza vaccine roll-out in NSW.
    Fizzell J; Campbell-Lloyd S; Hallett AJ; Lowbridge CP; Meijer D; Tyner SE
    N S W Public Health Bull; 2010; 21(1-2):32-5. PubMed ID: 20374692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything.
    Conway JM; Tuite AR; Fisman DN; Hupert N; Meza R; Davoudi B; English K; van den Driessche P; Brauer F; Ma J; Meyers LA; Smieja M; Greer A; Skowronski DM; Buckeridge DL; Kwong JC; Wu J; Moghadas SM; Coombs D; Brunham RC; Pourbohloul B
    BMC Public Health; 2011 Dec; 11():932. PubMed ID: 22168242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low adherence to influenza vaccination campaigns: is the H1N1 virus pandemic to be blamed?
    Trivellin V; Gandini V; Nespoli L
    Ital J Pediatr; 2011 Nov; 37():54. PubMed ID: 22074674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.